261 related articles for article (PubMed ID: 2515218)
1. Interaction of L-dopa and GHRH on GH secretion in normal men.
Alba-Roth J; von Creytz C; Mehltretter G; Schopohl J; Müller OA; von Werder K
J Endocrinol Invest; 1989 Dec; 12(11):783-7. PubMed ID: 2515218
[TBL] [Abstract][Full Text] [Related]
2. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
3. Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man.
Giusti M; Lomeo A; Mazzocchi G; Torre R; Monachesi M; Sessarego P; Attanasio R; Giordano G
J Endocrinol Invest; 1986 Dec; 9(6):497-501. PubMed ID: 3106459
[TBL] [Abstract][Full Text] [Related]
4. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
5. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
[TBL] [Abstract][Full Text] [Related]
6. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
7. The interaction of GHRH with TRH in acromegaly: a controlled study.
Looij BJ; Roelfsema F; Frölich M; Nieuwenhuijzen Kruseman AC
Acta Endocrinol (Copenh); 1991 Oct; 125(4):337-41. PubMed ID: 1957553
[TBL] [Abstract][Full Text] [Related]
8. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.
Zanoboni A; Gibillini M; Cucchi MR; Zanoboni Muciaccia W; Zanussi C
J Endocrinol Invest; 1988 Jun; 11(6):413-7. PubMed ID: 3145297
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
11. Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.
Garcia RV; Andrade A; Perez J; Courel M; Casanueva FF
J Endocrinol Invest; 1991 May; 14(5):383-9. PubMed ID: 1908493
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hypothalamic-pituitary function in a combination of tests with four hypothalamic releasing hormones and L-dopa in normal subjects and in patients with hypothalamic and/or pituitary disorders.
Bando H; Yamasaki R; Saito S
Endocrinol Jpn; 1989 Oct; 36(5):705-20. PubMed ID: 2559840
[TBL] [Abstract][Full Text] [Related]
13. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.
Van den Berghe G; Wouters P; Bowers CY; de Zegher F; Bouillon R; Veldhuis JD
Eur J Endocrinol; 1999 Jan; 140(1):17-22. PubMed ID: 10037246
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of hexarelin on TRH-induced TSH response in normal adult man.
Arosio M; Casati G; Biella O; Porretti S; Imbimbo BP; Faglia G
J Endocrinol Invest; 1998 Apr; 21(4):239-44. PubMed ID: 9624598
[TBL] [Abstract][Full Text] [Related]
17. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
Looij BJ; Nieuwenhuijzen Kruseman AC; Mudde AH; Frölich M; Piaditis GP; Hodgkinson SC; McLean C; Grossman A; Coy DH; Rees LH
Clin Endocrinol (Oxf); 1986 Feb; 24(2):149-56. PubMed ID: 2871949
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
Page MD; Dieguez C; Valcavi R; Edwards C; Hall R; Scanlon MF
Clin Endocrinol (Oxf); 1988 May; 28(5):551-8. PubMed ID: 3145820
[TBL] [Abstract][Full Text] [Related]
19. Effect of subacute cabergoline treatment on prolactin, thyroid stimulating hormone and growth hormone response to simultaneous administration of thyrotrophin-releasing hormone and growth hormone-releasing hormone in hyperprolactinaemic women.
Giusti M; Lomeo A; Torre R; Sghedoni D; Mazzocchi G; Durante R; Giordano G
Clin Endocrinol (Oxf); 1989 Mar; 30(3):315-21. PubMed ID: 2574083
[TBL] [Abstract][Full Text] [Related]
20. Discordance between growth hormone (GH) responses after GH-releasing hormone and insulin hypoglycemia in myotonic dystrophy.
Okimura Y; Chihara K; Kita T; Kashio Y; Sato M; Kitajima N; Abe H; Takahashi K; Fujita T
J Clin Endocrinol Metab; 1988 Nov; 67(5):1074-9. PubMed ID: 3141449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
